Citing concern over vaccine efficacy against emerging variants, Pfizer seeks approval for a third booster, but many are not yet convinced it is necessary.

Citing concern over vaccine efficacy against emerging variants, Pfizer seeks approval for a third booster, but many are not yet convinced it is necessary.
Integrating vaccines with biomaterials could help minimize the need for refrigeration and booster shots.
Bioorthogonal hydroamination of activated linear alkynes now suitable in living cells.
With a long history of development, mRNA vaccines are finally making their debut and changing the face of the COVID-19 pandemic.
Viruses are so varied and evolve so quickly that creating effective treatments against them becomes a daunting task.
A new lab-on-chip technology enables the rapid and quantitative identification of malaria parasites in the blood for better and more accurate diagnosis in remote regions.
Emerging data from trials exploring mixing different types of vaccines demonstrate the practice is safe and could boost immunity.
With research groups spread over two continents, Osier is striving to eliminate malaria through her groundbreaking work in immunology, advocacy and awareness.
Assays using pseudoviruses have been indispensable in our efforts to halt the current pandemic.
First and foremost, the goal is to keep people out of hospitals. The good news is all of the currently approved vaccines do just that.